Perfil das células germinativas após degeneração testicular induzida pelo busulfan

• Ano de defesa: 2013
• Autor(a) principal: Gutierrez, Karina
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal de Santa Maria; BR; Medicina Veterinária; UFSM; Programa de Pós-Graduação em Medicina Veterinária
• Palavras-chave em Português: Células-tronco espermatogoniais; Expressão gênica; Camundongos; Balb/C; Swiss; Spermatogonial stem cells; Gene expression; Mice; CNPQ::CIENCIAS AGRARIAS::MEDICINA VETERINARIA
• Link de acesso: http://repositorio.ufsm.br/handle/1/10152

The chemotherapeutic busulfan is widely used in studies of spermatogonial stem cells kinetics and studies of male infertility. However it effects on male germ cells in different animal lineages or species are unclear. The objective of this study was to assess the damage caused by busulfan in male mice spermatogenesis of two distinct lineages. The analyzed parameters were the mRNA pattern expression profile of spermatogonial stem cells (SSC) markers, analysis of spermatozoa motility, vigor and morphology, germinal epithelium histology and fertility recovery analysis. The animals received a single dose of 40 mg kg-1 of busulfan or vehicle. Past 30 days of the drug injection, the mice were weighted and anesthetized and had one of the testes and epididymis surgically removed. This procedure did not cause any damage to the other testis, once mice that had one of the testes removed were capable to generate offspring. From these testes, were evaluated the tissue histology and mRNA gene expression of spermatogonial stem cell (SSC) markers. The motility, vigor and spermatozoa morphology were analyzed from cauda epididymal spermatozoa. After 90 days of the drug injection, the mice were weighted, anesthetized and had the other testis removed for the same analyzes procedure. The analysis at 30 and 90 days after drug injection were from the same animals, minimizing the variation in individual response between periods. It was observed that, for Balb/C lineage, independent of the analyzed period, the busulfan treated animals showed a severe testicular degeneration, with loss of SSC, decreased motility and spermatozoa vigor and increased number of defective spermatozoa. In mRNA expression it was observed a marked reduction in Nanos2 expression, and an increase in Gdnf and Plzf gene expression. For animals of Swiss lineage, it was observed that at 30 days after the busulfan injection, the results obtained were similar to that obtained for Balb/C lineage, except in gene expression, which remained unchanged. However, 90 days after the drug injection, these animals show germinal epithelium almost normal, with spermatogenic lineage. They also show an increase in testicular and epididymal mass, spermatozoa motility and vigor and an increase in number of normal spermatozoa, did not differing from the control group. Moreover, this recovery was confirmed by the offspring obtained after matting with virgin females. The male mice utilized in these tests were not submitted to testes removal. These results shows the variation of busulfan effects in two distinct mice lineages, being the drug effective to cause a severe testicular degeneration for more than 90 days in Balb/C lineage, but not in Swiss lineage, due to genetic variations.